DONA

البلد: أرمينيا

اللغة: الإنجليزية

المصدر: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

العنصر النشط:

glucosamine (glucosamine sulfate)

متاح من:

Rottapharm Ltd.

INN (الاسم الدولي):

glucosamine (glucosamine sulfate)

جرعة:

1500mg, (20), (30) sachets

الشكل الصيدلاني:

powder for oral solution

نوع الوصفة الطبية :

Prescription

خصائص المنتج

rtli:J{wlldl;'qy
g
.sUMN,{ARIf,
..OF
PRODUCT
CI{ARACTERT$TICS
.NAME
O,F
T[,IS.
MED,TCINAL
PRODUCT
nOnl
n
l'SO0' mg'
:powtlo
r*
fsr,
sral,,solution,
'
.affiEIwtVE
ANF'
$U$ffTrTA^ff'r,VE
COMPOS
rrrqN
Effi
sachgt:,contains:
1884
mg
of
crystalline,glucosamiRe,sulfate,,eq:uivalent
to
1500
mg
of:gluoosamine
sulfate
and
384
mg
of
sodium
chloride.
Exgipientsr contains
aspaffame,
sor:bitol.
For:'a
:,fu
ll
l,ist,,of
excip
ients,,see
section
6.
I
.
$
4,"
:
P
IIARIvI#:e*
CAL,,FORM
howaun
ru't:ouat
*"tutii*,
Whit*,
sr*-stal
line
$owder
in
s
in
g
l
e,
dose
sashefs,,
,
,
,
|
,,.1
cElNrcAL,FA$FICULAR's
.i
Tfrerapeufic
ind
ie4tions
Treatment
of
the symptorns
of
osteoarthriris,
i;e.
pain
and
4iil
4.?,Posologycnd'methorlolf,,adrninistration
:
The
csntent
ofone,sachet
dhily,
dissolved
in:a,glass
of
water,
pieferably
at
meals,
i:1,
'r.'
''
',6lucosarnine,
,is:not
.indicated
for
the,treatment
of,,acute
painftrf
symptoms.
Relief
of
::i:
i,
.
SJrnptomS''(espec,ialln
OUin,relie$,111sf
nst,'be,experiensed
until
after
some
weeks
of
i':..'.'....'''lfeof.ment.and'''in...somg.ic4sesiev€n.'.Ionger'If''noreliefofs'yrnptomsis.eNperienedafer
,'..
,.,,,,,.,,.,
,,:,213,
mOnth$;lcOntihUeid
t$trnentW,ith,g,fulcgSam,ine
should,be
re-eval,11ated.
'
'
.
The'saryanO].effi
-
of
gti,cotamine:iulf-ate
hnve-
been,confirynedrin
clinical
trials
for
:
i
treatment
up,{p,fh1€E}€drs.
''''
.,
1,.,:1i:jr:;'r-i''
,i,,
:
AddiriaaatWrtnation
anipeeiulpopuldtions
'
'
efiildten,larid,,A(loleigents'
'
'"
.
.
Clusosamins
shoufdr,not,
$s
used
in
ehildren
and adolescents
below
the
age
of
18
years
'
,"
'(bee,4.4)'
i
:
'
',g1ilsvtry:'
,';
;;
:;,.,1116
gp*
experience
dosage
adjustment
is
not requircd
when
treating
otherwise healthy,
elderly
patients"
i
'
ftnpairvil
i{ttnl
nndlor,,tiverfattctio'n
',
'::
'
',1n
pafient*
with,rirhpaired
,tenaf
cndlor
liver
firnotion
no
dose
resornrne$dations
can
be
,
',,',
.,
givenr
sihds no'studiesthavefu66;:perforrnsd,(seetalso:Se0tion
4.4),
function limitation.
ffi,ffi
,ffilena,Miag,ura
ff'nuntqyl#is
MHSA
Fha
Fte,gl
r*xtffie:ss.,SS
ff{:{;